The hemovigilance experts — John Roback, MD, PhD; Pierre Robillard, MD; Mark Fung, MD, PhD; Kamille West, MD; and AABB Senior Director of Research Barbee Whitaker, PhD — were back to challenge annual meeting attendees to identify and code adverse transfusion reactions based on CDC National Healthcare Safety Network (NHSN) Hemovigilance Module definitions, which were provided.
Presented with case studies, audience members answered multiple-choice questions on whether the cases represented transfusion reactions and, if so, which type. The audience was also asked what additional info would help them make that determination, how well each determination matched the CDC case definition, the severity of the reaction and the reaction’s imputability, or to what degree did the transfusion cause the reaction. Finally, audience members were asked what they would do with the donors who contributed to the reaction.
Coding transfusion reactions can be a tricky proposition, but practice makes perfect.
— Jerilyn Schweitzer